INmune Bio (INMB) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
INmune Bio, Inc. (INMB) is a biotech startup developing anti-brain inflammation treatments for dementia therapy using specific TNF inhibitors. The visualization of financial quotes based on the EV/EBITDA metric stands at 0.00, which complements data regarding management's strategy for conducting clinical trials. Since there are no commercial sales, the asset's market value is based entirely on FDA trial results.
inmunebio.com - analytical breakdowns and key metrics (INMB)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
INMB - Net Income|Future Profit INmune Bio, Inc.|INMB - P/E Multiple|Future Price to Earnings INmune Bio, Inc.|INMB - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple INmune Bio Corporation|INMB - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months INmune Bio|INMB - Earnings per share for the trailing year|Quarterly EPS earnings growth inmunebio.com|INMB - Earnings per share growth in current year|Earnings growth forecast for next year INmune Bio, Inc.
Initial company analysis:INmune Bio Corp INMB
The market views INmune Bio, Inc. (INMB) as a high-risk asset, where calculating business value relative to operating profit allows for the identification of the real debt load without tax distortions. Analyzing the EV/EBITDA multiple reveals the specifics of the biotech sector: the absence of revenue during the clinical trial stage turns this indicator into a marker of the company's dependence on external financing.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ABCL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to EBITDA Ratio Precigen Inc (PGEN)|Enterprise Value to EBITDA Ratio PHAR (Pharming)|EV/EBITDA Multiple Nektar Corp (NKTR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|ZBIO: Enterprise Value to Operating Income Before Depreciation|Immunome - EV/EBITDA Multiple|Company Value to EBITDA Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Septerna Pharma - Business Value to Operating Income Before Depreciation|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SVRA|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|enGene Corp (ENGN) - Company Value to EBITDA|RAPT: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation JBIO (Aerovate Therapeutics Inc)|ACRS: EV/EBITDA Multiple|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|Enterprise Value to Operating Income Before Depreciation CABA (Cabaletta Bio Inc)|EV/EBITDA Multiple VTYX|Enterprise Value to EBITDA Ratio theratech.com THTX|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Eledon Pharmaceuticals Inc. (ELDN)|Agenus Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Climb Bio, Inc CLYM|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ATYR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|Enterprise Value to EBITDA Ratio Ikena Oncology, Inc. (IMA)|EV/EBITDA Multiple STTK|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization EQ (equilliumbio.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|IMUX (Immunic Therapeutics) - Company Value to Operating Income Before Depreciation Ratio|Atara Biotherapeutics Inc - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation IFRX (InflaRx N.V.)|XFOR: EV/EBITDA Multiple|Adicet Bio, Inc. (ACET) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|BRNS: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOVX (geovax.com)|EDSA: EV/EBITDA Multiple|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple aimimmuno.com AIM|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX: EV/EBITDA Multiple|Company Value to EBITDA reshapelifesciences.com (HIND)|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Indaptus Therapeutics Inc (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|calcimedica.com - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK - Enterprise Value to EBITDA Ratio|HOOK: Enterprise Value to EBITDA Ratio|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation OCEA|TCBP (TC Biopharm) - EV/EBITDA Multiple|Company Value to EBITDA thirdharmonicbio.com THRD
